Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.
3.

Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.

Kurman RJ, Vang R, Junge J, Hannibal CG, Kjaer SK, Shih IeM.

Am J Surg Pathol. 2011 Nov;35(11):1605-14. doi: 10.1097/PAS.0b013e318229449f.

5.

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.

Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D.

Gynecol Oncol. 2008 Sep;110(3):408-17. doi: 10.1016/j.ygyno.2008.05.010. Epub 2008 Jul 1.

PMID:
18597838
6.
7.

Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?

Yanai-Inbar I, Siriaunkgul S, Silverberg SG.

Int J Gynecol Pathol. 1995 Apr;14(2):107-13.

PMID:
8601521
8.
9.

Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?

Seidman JD, Sherman ME, Bell KA, Katabuchi H, O'Leary TJ, Kurman RJ.

Int J Gynecol Pathol. 2002 Apr;21(2):101-7.

PMID:
11917218
10.

Early adenocarcinoma of the fallopian tubes. A case for multifocal tumorigenesis.

Bannatyne P, Russell P.

Diagn Gynecol Obstet. 1981 Spring;3(1):49-60.

PMID:
7215124
11.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Vang R, Shih IeM, Kurman RJ.

Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Review.

PMID:
23240669
12.
13.
14.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
15.

Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.

Culton LK, Deavers MT, Silva EG, Liu J, Malpica A.

Am J Surg Pathol. 2006 Jul;30(7):844-9.

PMID:
16819326
16.

Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.

Hogg R, Scurry J, Kim SN, Friedlander M, Hacker N.

Gynecol Oncol. 2007 Jul;106(1):44-51. Epub 2007 Apr 27.

PMID:
17467045
17.

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.

Silva EG, Gershenson DM, Malpica A, Deavers M.

Am J Surg Pathol. 2006 Nov;30(11):1367-71.

PMID:
17063075
20.

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.

Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG.

Am J Surg Pathol. 2002 Sep;26(9):1129-41.

PMID:
12218569

Supplemental Content

Support Center